WIN 2022 Program

INTEGRATING GENOMICS AND TRANSCRIPTOMICS TO RESHAPE PRECISION ONCOLOGY:
A WINNING STRATEGY

Sunday 30 October 2022

SESSION 3 – DISRUPTIVE CONCEPTS AND METHODOLOGICAL INNOVATIONS IN NSCLC: MEET THE EXPERTS

Image Description

08:30

Keynote Lecture

Overview of advances in lung cancer

Enriqueta Felip

Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

Image Description

08:55

From chest x ray to AI-assisted lung cancer screening and early detection program in Israel

Amir Onn

Sheba Medical Center, Ramat Gan, Israel

Image Description

09:20

Individualized surgical treatment strategy for early-stage lung cancer: Translation of knowledge

Haiquan Chen

Fudan University, Shanghai, China

Image Description

09:45

Neoadjuvant and adjuvant treatments in NSCLC

Jair Bar

Sheba Medical Center, Ramat Gan, Israel

Image Description​​

10:10

New drugs for SCLC

Pilar Garrido

Universidad de Alcalá, Madrid, Spain

10:35

Panel Discussion and Q&A from the Audience

 

 

11:00

Coffee and Networking

SESSION 4 - WIN FIRST INTERNATIONAL MOLECULAR TUMOR BOARD: A STRATEGIC PLACE IN ADVANCING PRECISION ONCOLOGY

Image Description

11:30

First WIN International Molecular Tumor Board

Introduction

Patients' cases presentation by investigators. Discussion and treatment recommendation

Moderator

Razelle Kurzrock

WIN Consortium, Villejuif, France

12:35

Panel Discussion and Q&A from the audience

13:00

Lunch, poster viewing and networking

SESSION 5 –​ WHAT IS NEW IN BREAST, CRC, HEAD & NECK, AND PEDIATRIC CANCERS?

 

14:00

Opening Keynote Lecture

 

   

Image Description

14:25

Keynote Lecture

Novel CRC insights based on combined genomic and
transcriptomic data at both bulk and single cell level, leading to new therapeutically relevant CRC classification

Sabine Tejpar

University of Leuven, Belgium

Image Description

14:50

Serial profiling in metastatic CRC; beyond the tip of the iceberg

Gerald Batist

Segal Cancer Centre, Lady Davis Institute at the JGH, McGill University, Montréal, Canada

Image Description

15:15

Proteogenomic analysis of triple negative breast cancer (TNBC) response to neoadjuvant chemotherapy

Matthew Ellis

AstraZeneca, Gaithersburg, Maryland, USA

Image Description

15:40

Novel strategies in head & neck cancers

Christophe Le Tourneau

Institut Curie, Paris, France

Image Description

16:05

Pediatric European Precision Cancer Medicine Program - Facing cancer complexity

Birgit Geoerger

Gustave Roussy, Villejuif, France
ITCC

16:55

BEST TWO POSTERS' PRESENTATIONS AND AWARDS

Josep Tabernero, Vice-Chairman WIN Consortium, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

Amir Onn, Head of the Standard Operating Procedures and repository Committee WIN Consortium
Chair, Institute of Pulmonary Medicine, Sheba Medical Center, Israel

17:20

CONCLUSIONS

Richard L. Schilsky, Chairman WIN Consortium

 

Download the WIN 2022 Program

Download the Program Here

WIN 2022 Symposium
c/o MCI UK Ltd
Ground Floor, Building 1000
Western Road
Portsmouth, Hampshire
PO6 3EZ, UK

Tel: +44 (0) 1730 715223
General enquiries: winsymposium@mci-group.com
Sponsorship enquiries: winsymposium@mci-group.com
Abstract enquiries: winsympabstracts@mci-group.com
Registration enquiries: winsympreghot@mci-group.com

View Our Privacy Policy Here